Free Trial
→ Free Stock Ticker Inside: This Indicator Caught Nvidia’s Rallies (From ProsperityPub) (Ad) Free SUPN Stock Alerts

Supernus Pharmaceuticals (SUPN) SEC Filings & 10K Form

Supernus Pharmaceuticals logo
$37.74 -0.13 (-0.34%)
As of 01/17/2025 04:00 PM Eastern
Compare

Recent Supernus Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
12/30/2024
3:13 PM		Rubin Jonathan (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:08 PM		Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
7:42 AM		Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
7:31 AM		Rubin Jonathan (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
3:31 PM		Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
4:00 PM		Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
3:19 PM		GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
3:08 PM		Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
3:11 PM		GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
3:59 PM		Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2024
3:42 PM		GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/04/2024
3:19 PM		Supernus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2024
3:35 PM		MACQUARIE GROUP LTD (Filed by)
Supernus Pharmaceuticals (Subject)
Form SC 13G/A
10/31/2024
10:55 AM		DIMENSIONAL FUND ADVISORS LP (Filed by)
Supernus Pharmaceuticals (Subject)
Form SC 13G
10/21/2024
3:48 PM		Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
3:16 PM		Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
4:03 PM		Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2024
3:30 PM		GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
4:00 PM		Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
6:03 AM		Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
3:16 PM		Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
3:18 PM		Supernus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
3:19 PM		Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/31/2024
3:41 PM		Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/24/2024
3:48 PM		Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/23/2024
3:20 PM		Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2024
3:24 PM		Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/19/2024
3:28 PM		Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
3:14 PM		Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
3:18 PM		Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
3:53 PM		Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
4:15 PM		Supernus Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/09/2024
3:09 PM		Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
3:05 PM		Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
3:08 PM		Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2024
7:03 AM		Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
4:00 PM		Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
4:00 PM		Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
4:01 PM		Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
5:39 PM		Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
4:00 PM		Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
AAPL: Double Your Returns in 24 Hours? (Ad)

Trader Chris Pulver is diving deep into the inner workings of Wall Street... To reveal a trading method he’s kept under wraps for years. You see… Thanks to “liquidity levels” which show us Wall Street’s biggest undercover buy orders in real time… This method has shown the ability to DOUBLE our returns…

You can see them—along with the finer details of how his strategy works—on this page right here.
03/13/2024
3:23 PM		Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
4:00 PM		Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:01 PM		Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
4:28 PM		Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
1:33 PM		ARMISTICE CAPITAL, LLC (Filed by)
Supernus Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2024
6:06 AM		MACQUARIE GROUP LTD (Filed by)
Supernus Pharmaceuticals (Subject)
Form SC 13G
02/05/2024
8:21 AM		Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:SUPN) was last updated on 1/20/2025 by MarketBeat.com Staff
From Our Partners
Last time you’ll see this priced at $1.00
When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...
StocksToTrade | Sponsored
Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong
Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...
Brownstone Research | Sponsored
Kamala’s final humiliation
The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...
Porter & Company | Sponsored
Must-See: 5-Second Trump Prediction
President Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...
InvestorPlace | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
January 29th - the next big trading catalyst to watch
Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...
Timothy Sykes | Sponsored
We recommended Palantir in 2021, now we’re recommending this...
I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...
Behind the Markets | Sponsored
Grab This Altcoin Before Trump's Crypto Announcement
The #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...
Crypto 101 Media | Sponsored